Straten PT - Search Results

1

Towards discovery-driven translational research in breast cancer.

Celis JE, Moreira JM, Gromova I, Cabezon T, Ralfkiaer U, Guldberg P, Straten PT, Mouridsen H, Friis E, Holm D, Rank F, Gromov P. Celis JE, et al. Among authors: straten pt. FEBS J. 2005 Jan;272(1):2-15. doi: 10.1111/j.1432-1033.2004.04418.x. FEBS J. 2005. PMID: 15634327 Free article. Review.

2

T-cell receptor clonotype mapping using denaturing gradient gel electrophoresis : analysis of clonal T-cell responses in melanoma.

Straten PT, Becker JC, Zeuthen J, Guldberg P. Straten PT, et al. Methods Mol Med. 2001;61:339-51. doi: 10.1385/1-59259-145-0:339. Methods Mol Med. 2001. PMID: 22323267

3

Identification of identical TCRs in primary melanoma lesions and tumor free corresponding sentinel lymph nodes.

Straten Pt, Dahl C, Schrama D, Pedersen LØ, Andersen MH, Seremet T, Bröcker EB, Guldberg P, Becker JC. Straten Pt, et al. Cancer Immunol Immunother. 2006 May;55(5):495-502. doi: 10.1007/s00262-005-0023-8. Epub 2005 Jul 7. Cancer Immunol Immunother. 2006. PMID: 16001163 Free PMC article.

4

Aberrant p27Kip1 promoter methylation in malignant melanoma.

Worm J, Bartkova J, Kirkin AF, Straten P, Zeuthen J, Bartek J, Guldberg P. Worm J, et al. Oncogene. 2000 Oct 19;19(44):5111-5. doi: 10.1038/sj.onc.1203891. Oncogene. 2000. PMID: 11042700

5

Activation of preexisting T cell clones by targeted interleukin 2 therapy.

Straten PT, Guldberg P, Seremet T, Reisfeld RA, Zeuthen J, Becker JC. Straten PT, et al. Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8785-90. doi: 10.1073/pnas.95.15.8785. Proc Natl Acad Sci U S A. 1998. PMID: 9671756 Free PMC article.

6

Immunogenicity of constitutively active V599EBRaf.

Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, Berger TG, Schadendorf D, Trefzer U, Bröcker EB, Straten Pt, Rapp UR, Becker JC. Andersen MH, et al. Among authors: straten pt. Cancer Res. 2004 Aug 1;64(15):5456-60. doi: 10.1158/0008-5472.CAN-04-0937. Cancer Res. 2004. PMID: 15289355

7

Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.

Grønbaek K, Straten PT, Ralfkiaer E, Ahrenkiel V, Andersen MK, Hansen NE, Zeuthen J, Hou-Jensen K, Guldberg P. Grønbaek K, et al. Among authors: straten pt. Blood. 1998 Nov 1;92(9):3018-24. Blood. 1998. PMID: 9787134 Free article.

8

Immunogenicity of Bcl-2 in patients with cancer.

Andersen MH, Svane IM, Kvistborg P, Nielsen OJ, Balslev E, Reker S, Becker JC, Straten PT. Andersen MH, et al. Among authors: straten pt. Blood. 2005 Jan 15;105(2):728-34. doi: 10.1182/blood-2004-07-2548. Epub 2004 Sep 14. Blood. 2005. PMID: 15367432 Free article.

9

A survivin specific T-cell clone from a breast cancer patient display universal tumor cell lysis.

Sørensen RB, Svane IM, Straten PT, Andersen MH. Sørensen RB, et al. Among authors: straten pt. Cancer Biol Ther. 2008 Dec;7(12):1885-7. doi: 10.4161/cbt.7.12.6935. Epub 2008 Dec 7. Cancer Biol Ther. 2008. PMID: 18927499

10

HLA-B35-restricted immune responses against survivin in cancer patients.

Reker S, Becker JC, Svane IM, Ralfkiaer E, Straten PT, Andersen MH. Reker S, et al. Among authors: straten pt. Int J Cancer. 2004 Mar 1;108(6):937-41. doi: 10.1002/ijc.11634. Int J Cancer. 2004. PMID: 14712500 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page